Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors
Clinical trial NCT02313012 · TERMINATED
Trial details
- NCT number
- NCT02313012
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-05
- Primary completion
- 2016-05-03
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.